DTL
NPCE icon

Dynamic Technology Lab’s Neuropace NPCE Stock Holding History

Dynamic Technology Lab’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$223K Buy
+16,956
New +$254K 0.04% 710

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dynamic Technology Lab's NPCE Position: Q1 2026 in Review

Dynamic Technology Lab opened a new position in Neuropace (NPCE) in Q1 2026: 16,956 shares worth $223K. The stake represents 0.04% of the portfolio and ranks #710 among its holdings.

113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Dynamic Technology Lab held 16,956 shares of Neuropace worth $223K as of Q1 2026.
  • Neuropace was a new Dynamic Technology Lab position in Q1 2026.
  • Neuropace made up 0.04% of Dynamic Technology Lab's portfolio in Q1 2026, its #710 holding.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Dynamic Technology Lab's 13F filing for Q1 2026, filed 15 May 2026.